Cargando…

Drug-Induced Interstitial Lung Disease: A Systematic Review

Background: Drug-induced interstitial lung disease (DIILD) occurs as a result of numerous agents, but the risk often only becomes apparent after the marketing authorisation of such agents. Methods: In this PRISMA-compliant systematic review, we aimed to evaluate and synthesise the current literature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skeoch, Sarah, Weatherley, Nicholas, Swift, Andrew J., Oldroyd, Alexander, Johns, Christopher, Hayton, Conal, Giollo, Alessandro, Wild, James M., Waterton, John C., Buch, Maya, Linton, Kim, Bruce, Ian N., Leonard, Colm, Bianchi, Stephen, Chaudhuri, Nazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209877/ https://www.ncbi.nlm.nih.gov/pubmed/30326612 http://dx.doi.org/10.3390/jcm7100356

Ejemplares similares

How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians
por: Eaden, James A., et al.
Publicado: (2020)

Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience
por: Rivera-Ortega, Pilar, et al.
Publicado: (2018)

Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review
por: Hayton, Conal, et al.
Publicado: (2019)

The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening
por: Balata, Haval, et al.
Publicado: (2023)

Beware Weakening the Ivory Tower of MDT Diagnosis in Interstitial Lung Disease
por: Chaudhuri, Nazia, et al.
Publicado: (2019)

Idiopathic Pulmonary Fibrosis (IPF): An Overview
por: Barratt, Shaney L., et al.
Publicado: (2018)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

Transbronchial Lung Cryobiopsy in Idiopathic Pulmonary Fibrosis: A State of the Art Review
por: Lodhi, Taha, et al.
Publicado: (2019)

Experimental and quantitative imaging techniques in interstitial lung disease
por: Weatherley, Nicholas D, et al.
Publicado: (2019)

A Review of the Multidisciplinary Diagnosis of Interstitial Lung Diseases: A Retrospective Analysis in a Single UK Specialist Centre
por: Chaudhuri, Nazia, et al.
Publicado: (2016)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
por: Hughes, Gareth, et al.
Publicado: (2016)

Post-COVID Interstitial Lung Disease—The Tip of the Iceberg
por: Kewalramani, Namrata, et al.
Publicado: (2023)

Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
por: Johnston, Janet, et al.
Publicado: (2023)

Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis
por: Giollo, Alessandro, et al.
Publicado: (2020)

Hyperpolarised xenon-129 diffusion-weighted magnetic resonance imaging for assessing lung microstructure in idiopathic pulmonary fibrosis
por: Eaden, James A., et al.
Publicado: (2023)

Lung MRI with hyperpolarised gases: current & future clinical perspectives
por: Stewart, Neil J, et al.
Publicado: (2022)

Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE
por: Skeoch, S, et al.
Publicado: (2014)

Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI
por: Weatherley, Nicholas D, et al.
Publicado: (2021)

Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)
por: Wild, Jim M, et al.
Publicado: (2021)

Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service
por: Robey, Rebecca C., et al.
Publicado: (2021)

Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation
por: Skeoch, S., et al.
Publicado: (2017)

Real world experience of response to pirfenidone in patients with idiopathic pulmonary fibrosis: a two centre retrospective study
por: Eaden, James A., et al.
Publicado: (2020)

Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF
por: Weatherley, Nicholas D, et al.
Publicado: (2019)

Xenon ventilation MRI in difficult asthma: initial experience in a clinical setting
por: Mussell, Grace T., et al.
Publicado: (2021)

Comment from the Editor of the Special Issue: “Lung Disease on COPD, Asthma, Bronchiectasis, Lung Cancer Screening, IPF”
por: Chaudhuri, Nazia
Publicado: (2019)

Efficacy of interleukin-1 blockade in Schnitzler’s syndrome without detectable monoclonal gammopathy: a case-based review
por: Bixio, Riccardo, et al.
Publicado: (2020)

Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index
por: Carter, Lucy M, et al.
Publicado: (2022)

Reply to Althuwaybi et al.: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease: A Potential Role for Aerodigestive Pathophysiology?
por: Chaudhuri, Nazia, et al.
Publicado: (2021)

Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey
por: Ngamjanyaporn, Pintip, et al.
Publicado: (2017)

Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases
por: Viani, Magda, et al.
Publicado: (2022)

Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
por: Toellner, Hannah, et al.
Publicado: (2017)

The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021)

A case report of radiopharmaceutical needlestick injury with scintigraphic imaging and dose quantification
por: Elliott, James, et al.
Publicado: (2022)

Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors
por: Haque, Sahena, et al.
Publicado: (2018)

Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment
por: Noor, Saba, et al.
Publicado: (2020)

Survey of water proton longitudinal relaxation in liver in vivo
por: Waterton, John Charles
Publicado: (2021)

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases
por: Swigris, Jeffrey J., et al.
Publicado: (2018)

Committing to Place: The Potential of Open Collaborations for Trusted Environmental Governance
por: Waterton, Claire, et al.
Publicado: (2015)

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pv6vfqds01iejlppoh43iibm8g